Sort
64,565 grants matching “drug discovery”
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2022 · DA
New Catalytic Reactions for Enhanced Synthetic Efficiency
$880,000Barry M Trost · Stanford University · · FY2014 · MPS
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Research Center · DP1 · FY2020 · DA
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
$879,889Subramaniam Ananthan · Southern Research Institute · R01 · FY2016 · DA
Next-Generation Antibody Discovery and Development Technology
$879,836David Scott Johnson · Gigagen, Inc. · R44 · FY2016 · CA
CVD in American Indians Study and Data Management Center and OK Field Center
$879,647Elisa Lee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2014 · HL
Project 4 - Influenza - UAB
$879,614Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2020 · AI
Methods development for "Omics" data
$879,602Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans
$879,580Ravindranath Duggirala · Texas Biomedical Research Institute · U01 · FY2012 · DK
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$879,530Daniel E Kahne · Harvard Medical School · U19 · FY2015 · AI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$879,508Thomas G Bernhardt · Harvard Medical School · U19 · FY2014 · AI
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$879,352Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Screening Complete TB Proteome for Protective Antigens
$879,258Alan Greener · Gene Therapy Systems, Inc. · R44 · FY2008 · AI
Systematic Investigation of Protein Ubiquitination in ARDS
$879,209Beibei Chen · University Of Pittsburgh At Pittsburgh · R35 · FY2020 · HL
Institute for Biomedical and Health Disparities Research
$879,006Barbara Elaine Hayes · Texas Southern University · G12 · FY2011 · RR
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse
$878,896Gary A Peltz · Stanford University · U01 · FY2019 · DA
Discovery and development of GPR3 agonists for nicotine cessation
$878,861Elaine Arrington Gay · Research Triangle Institute · R01 · FY2023 · DA
Center for Testing Potential Anti-Aging Interventions
$878,677Randy Strong · University Of Texas Hlth Science Center · U01 · FY2019 · AG
Development of an inhibitory oligonucleotide for the treatment of lupus
$878,519Robert L Coffman · Dynavax Technologies Corporation · R44 · FY2008 · AI
A data-driven approach towards generation of permeable peptide therapeutics
$878,452Parisa Hosseinzadeh · University Of Oregon · DP2 · FY2024 · GM
Integrative Omics to enhance therapeutics development for healthy aging
$878,314Nicholas Joseph Schork · Translational Genomics Research Inst · UH3 · FY2023 · AG
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$878,282Tracy M Handel · University Of California, San Diego · U01 · FY2011 · GM
Preclinical discovery of novel farnesyltransferase inhibitors for the treatment of Alzheimer's disease and related tauopathies
$878,176Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AG
Center for Genomics and Society
$878,079Gail E Henderson · Univ Of North Carolina Chapel Hill · P50 · FY2012 · HG
Group II mGluR antagonists and negative modulators in depression
$878,070Athina Markou · University Of California, San Diego · R01 · FY2011 · MH